Cannasat Therapeutics Inc. Reports Results for the Three Months Ended March 31, 2007

TORONTO, ONTARIO -- (MARKET WIRE) -- May 23, 2007 -- Cannasat Therapeutics Inc. (TSX VENTURE: CTH), the developer of novel cannabinoid-based pharmaceutical products, today announced its results for the three months ended March 31, 2007.
MORE ON THIS TOPIC